Arcoma AB (OSTO:ARCOMA) Cyclically Adjusted Book per Share: kr4.38 (As of Mar. 2026)


OSTO:ARCOMA Arcoma AB OSTO:ARCOMA
75 GF Score
Price kr8.22
GF Value kr7.86
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Arcoma AB Cyclically Adjusted Book per Share?

Arcoma AB OSTO:ARCOMA -2.14% 75 Cyclically Adjusted Book per Share is kr4.38 as of Mar. 2026. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.86 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Arcoma AB's adjusted book value per share for the three months ended in Mar. 2026 was kr5.279. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr4.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Arcoma AB's average Cyclically Adjusted Book Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-07), Arcoma AB's current stock price is kr8.22. Arcoma AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr4.38. Arcoma AB's Cyclically Adjusted PB Ratio of today is 1.88.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Arcoma AB was 2.41. The lowest was 0.33. And the median was 0.82.


Arcoma AB  (OSTO:ARCOMA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Arcoma AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.22/4.38
=1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Arcoma AB was 2.41. The lowest was 0.33. And the median was 0.82.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Arcoma AB Cyclically Adjusted Book per Share Related Terms


Arcoma AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Arcoma AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcoma AB Cyclically Adjusted Book per Share Chart

Arcoma AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 20.95 4.54 4.38

Arcoma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.47 4.44 4.41 4.38 4.38

OSTO:ARCOMA vs ABT, SYK, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Arcoma AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcoma AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arcoma AB's Cyclically Adjusted PB Ratio falls into.


OSTO:ARCOMA
75GF Score
Arcoma AB OSTO:ARCOMA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcoma AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arcoma AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.279/133.5600*133.5600
=5.279

Current CPI (Mar. 2026) = 133.5600.

Arcoma AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.646 101.019 4.820
201609 3.532 101.138 4.664
201612 3.610 102.022 4.726
201703 3.710 102.022 4.857
201706 3.981 102.752 5.175
201709 3.217 103.279 4.160
201712 3.229 103.793 4.155
201803 3.089 103.962 3.968
201806 3.141 104.875 4.000
201809 3.132 105.679 3.958
201812 3.087 105.912 3.893
201903 3.114 105.886 3.928
201906 3.306 106.742 4.137
201909 3.468 107.214 4.320
201912 3.573 107.766 4.428
202003 3.805 106.563 4.769
202006 4.106 107.498 5.101
202009 4.249 107.635 5.272
202012 3.917 108.296 4.831
202103 3.968 108.360 4.891
202106 4.204 108.928 5.155
202109 3.948 110.338 4.779
202112 3.374 112.486 4.006
202203 3.268 114.825 3.801
202206 3.314 118.384 3.739
202209 3.367 122.296 3.677
202212 3.479 126.365 3.677
202303 3.310 127.042 3.480
202306 3.314 129.407 3.420
202309 3.464 130.224 3.553
202312 3.690 131.912 3.736
202403 4.006 132.205 4.047
202406 4.284 132.716 4.311
202409 4.475 132.304 4.517
202412 4.500 132.987 4.519
202503 4.655 132.825 4.681
202506 4.290 133.699 4.286
202509 5.129 133.480 5.132
202512 5.222 133.390 5.229
202603 5.279 133.560 5.279

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr4.38 mean?
Arcoma AB (OSTO:ARCOMA) has a Cyclically Adjusted Book per Share of kr4.38 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arcoma AB and its competitors.
Is Arcoma AB's Cyclically Adjusted Book per Share too high?
Arcoma AB's current Cyclically Adjusted Book per Share is kr4.38. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's Cyclically Adjusted Book per Share compare to ABT and SYK?
Arcoma AB's Cyclically Adjusted Book per Share of kr4.38 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arcoma AB and its competitors. Arcoma AB's current Cyclically Adjusted Book per Share is kr4.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Fairly Valued. The stock's GF Value™ is kr7.86, compared to a current price of kr8.22 — trading 4.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr4.38. Arcoma AB's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current Cyclically Adjusted Book per Share is kr4.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?

Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued. The current stock price of kr8.22 is trading 4.6% above its estimated GF Value™ of kr7.86. GuruFocus considers Arcoma AB to be Fairly Valued.

Key valuation signals for OSTO:ARCOMA:

  • Cyclically Adjusted Book per Share: kr4.38
  • GF Value™: kr7.86 vs. price of kr8.22 (4.6% above fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arcoma AB Business Description

Address Annavagen 1, Vaxjo, SWE, SE-352 46
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score

Get the complete analysis for OSTO:ARCOMA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr8.22
Price
kr7.86
GF Value